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Abstract: The consequences of two-week hindlimb suspension (HS) on skeletal muscle atrophy were
investigated in balanced diet-fed Fat-1 transgenic and C57BL/6 wild-type mice. Body composition
and gastrocnemius fatty acid composition were measured. Skeletal muscle force, cross-sectional area
(CSA), and signaling pathways associated with protein synthesis (protein kinase B, Akt; ribosomal
protein S6, S6, eukaryotic translation initiation factor 4E-binding protein 1, 4EBP1; glycogen synthase
kinase3-beta, GSK3-beta; and extracellular-signal-regulated kinases 1/2, ERK 1/2) and protein
degradation (atrophy gene-1/muscle atrophy F-box, atrogin-1/MAFbx and muscle RING finger 1,
MuRF1) were evaluated in the soleus muscle. HS decreased soleus muscle wet and dry weights
(by 43% and 26%, respectively), muscle isotonic and tetanic force (by 29% and 18%, respectively),
CSA of the soleus muscle (by 36%), and soleus muscle fibers (by 45%). Fat-1 transgenic mice had
a decrease in the ω-6/ω-3 polyunsaturated fatty acids (PUFAs) ratio as compared with C57BL/6
wild-type mice (56%, p < 0.001). Fat-1 mice had lower soleus muscle dry mass loss (by 10%) and
preserved absolute isotonic force (by 17%) and CSA of the soleus muscle (by 28%) after HS as
compared with C57BL/6 wild-type mice. p-GSK3B/GSK3B ratio was increased (by 70%) and MuRF-1
content decreased (by 50%) in the soleus muscle of Fat-1 mice after HS. Balanced diet-fed Fat-1 mice
are able to preserve in part the soleus muscle mass, absolute isotonic force and CSA of the soleus
muscle in a disuse condition.
Keywords: Fat-1 mice; muscle disuse atrophy; ω-3 PUFAs; hindlimb suspension; protein
synthesis/degradation signaling
1. Introduction
Skeletal muscle disuse-induced atrophy is associated with decreases in skeletal muscle mass,
cross-sectional area, contractile force, and protein synthesis signaling activity [1–4]. Physical exercise [5–9],
neuromuscular electrical stimulation [10,11], and dietary supplementation [12–15] are employed to
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attenuate skeletal muscle loss in patients and animal experimental models. ω-3 Polyunsaturated fatty
acids (PUFAs)-rich fish oil increases skeletal muscle function in elderly patients [16,17] and attenuates
skeletal muscle mass decrease induced by muscle immobilization [18] and cancer cachexia [19] in
rodents. ω-3 PUFAs activate protein synthesis (Protein kinase B/ mammalian target of rapamycin/p70
ribosomal protein S6 kinase, Akt/mTOR/p70S6K) [18,20–23] and inhibit protein degradation signaling
pathways (atrophy gene-1/muscle atrophy F-box, atrogin-1/MAFbx and muscle RING finger 1,
MuRF1) [18]. We recently reported [1] the effects of oral supplementation of “high dose” of either
eicosapentaenoic (EPA)- or docosahexaenoic (DHA)-rich fish oil on protein synthesis/degradation
signaling pathways in skeletal muscle mass loss induced by two weeks of hindlimb suspension (HS)
in rats. EPA-rich fish oil attenuated the changes induced by HS on 26S proteasome activity, CSA of
soleus muscle fibers, and levels of p-Akt, total p70S6K, p-p70S6K/total p70S6K, p-4EBP1 (eukaryotic
translation initiation factor 4E-binding protein 1), p-GSK3-beta (glycogen synthase kinase3-beta),
p-ERK (extracellular-signal-regulated kinases) 2, and total ERK 1/2 proteins. DHA-rich fish oil
attenuated the changes induced by HS on p-4EBP1 and total ERK1 levels [1].
Jiang X. Kang developed, in 2004, the Fat-1 transgenic mice that produce ω-3 PUFAs from dietary
ω-6 PUFAs [24]. Experimental models of spinal cord injury [25] and peripheral nerve injury [26]
were investigated in Fat-1 transgenic mice fed with a ω-6 PUFA-rich diet. The strain displayed
neuroprotective properties and the authors reported attenuation of skeletal muscle atrophy due to
peripheral nerve injury [26]. Whether the primary cause was an effect in the nervous system or in
skeletal muscle tissue itself was not addressed. Also, the loss of muscle mass in Fat-1 mice was not yet
evaluated using muscle atrophy experimental models that maintain neural activity.
The consequences of HS-induced muscle atrophy in balanced diet-fed Fat-1 mice were
investigated. The purpose was to investigate whether small changes in the ω-6/ω-3 PUFAs ratio,
in “long term”, would be able to attenuate skeletal muscle disuse-induced atrophy. For this purpose,
the following measurements were performed: body weight gain, hindlimb skeletal muscle wet and
dry mass, soleus muscle and soleus muscle fibers CSA and force production by the soleus muscle.
Skeletal muscle signaling pathways associated with protein synthesis (Akt, S6, 4EBP1, GSK3B and
ERK 1/2 content) and protein degradation (cathepsin L and 26S proteasome activities and contents of
atrogin-1/MAFbx and MuRF1) were also measured.
2. Materials and Methods
2.1. Animals
The animals were maintained at the Department of Physiology and Biophysics, Institute
of Biomedical Sciences, University of São Paulo under 12 hours light/dark cycle and food
(commercial diet; Nuvilab-CR1, Quimtia-Nuvital, Colombo, Brazil) and water ad libitum. Fat-1
transgenic heterozygous mice were cross-bread with C57BL/6 wild-type mice [24,27]. The offspring
genotypes were evaluated by standard RT-PCR (real time polymerase chain reaction) at 21 day-old to
confirm C57BL/6 wild-type mice or Fat-1 transgenic mice lineage (Figure S1A). Ethics Committee of
the Institute of Biomedical Sciences, University of São Paulo, approved the experimental protocols
used in this study (CEUA.138/2013).
2.2. Experimental Design
Eight-week-old mice were divided into four groups: C57BL/6 wild-type (C57BL/6, n = 20),
C57BL/6 wildtype submitted to hindlimb suspension (C57BL/6 + HS, n = 18), Fat-1 (Fat-1, n = 15), and
Fat-1 submitted to hindlimb suspension (Fat-1 + HS, n = 15). Total number of animals in the different
groups was in 3 separated sets of experiments. The animals were left to adapt to individual cages
for 3 days. Afterwards (at Day 0), the suspension of the hind limb was initiated and maintained for
two weeks. After this period, the mice were anesthetized by intraperitoneal injection of ketamine
(90 mg/kg b.w.) and xylazine (10 mg/kg b.w.), weighed and killed by exsanguination. Muscles (soleus,
Nutrients 2017, 9, 1100 3 of 16
gastrocnemius, plantaris, tibialis anterior and extensor digitorum longus (EDL)) of both limbs and
fat depots (subcutaneous, epididymal, retroperitoneal, and mesenteric) were removed, weighed and
stored at −80 ◦C.
Hindlimb Suspension (HS)
Same HS experimental protocol has been reported in studies by others [28,29] and in our previous
study in rats [1]. In short, the rats were maintained in individual special cages with the tail attached on
the top of the cage, using a tape. In this position, the hind limbs of the animals cannot contact the floor,
removing the mechanical loading and causing skeletal muscle disuse atrophy in the hind limbs.
2.3. Gastrocnemius Fatty Acid Composition
Fatty acid composition was determined in the gastrocnemius muscle (~30 mg of fresh tissue) by
gas chromatography using the AOAC 996.06 [30] and AOCS Ce 1j-07 [31] methods as described in our
previous studies [1,32]. The composition of fatty acids in the gastrocnemius muscle was expressed as
g/100 g tissue wet weight.
2.4. In Vivo Soleus Muscle Electrical Stimulation
The experimental protocol used was based on Wojtaszewski et al. [33] and Silveira et al. [34] with
modifications by Pinheiro et al. [35], Fortes et al. [36], and Abreu et al. [32]. This protocol was the same
described in our previous studies in rats [32,35,36]. The animals were anesthetized as described above
and fixed on an acrylic platform. The stimulated hind limb was fitted on the platform with the hip and
knee joints fixed at ~130◦ angle. A hook was placed under the Achilles tendon for measurement of the
contractile properties of the soleus muscle using a force transducer (Grass Technologies, West Warwick,
RI, USA), after tenotomy of synergistic and antagonist muscles. Electrical stimulation device MultiStim
System D330 (Digitimer Ltd, Welwyn Garden City, Hertfordshire, UK) connected to an electrode
placed at the sciatic nerve was used to promote soleus muscle contractions. The resting length (L0) of
the soleus muscle was adjusted to produce maximum tension upon stimulation (obtained with the
ankle joint at approximately 90◦ angle).
2.5. Analysis of Soleus Muscle Force and Contractile Properties
The procedures used were the same described in our previous studies for rats [32,35,36].
The AqDados software (version 4.16, Lynx Tecnologia Eletronica Ltda, São Paulo, Brazil) was used
to record the muscle isotonic force generated during twitches at 1 Hz frequency and 500 µs pulse
duration. Five contractions were used to calculate the absolute isotonic force production, time to
peak (TTP—time between the onset of force development until peak tension), half relaxation time
(HRT—time of muscle relaxation half-way from peak tension), and late relaxation time (LRT—time of
muscle relaxation between 50% and 25% of peak tension). The tension generated at 100 Hz and 500 µs
pulse duration was used to calculate muscle tetanic force. The absolute tetanic force was determined
through maximum force production obtained through voltage adjustment. The AqAnalysis software
(version 4.16, Lynx Tecnologia Eletronica Ltda, São Paulo, Brazil) was used to evaluate muscle force.
2.6. Analysis of Soleus Muscle Resistance to Fatigue
The procedure used was the same described in our previous studies in rats [32,37,38]. The skeletal
muscle fatigue-inducing protocol consisted of 10 tetanic contractions with 2 s duration each. The soleus
muscle was stimulated every 10 s and peak muscle force was obtained on each contraction for the
calculation of the area under the curve (force × contraction), named as muscle fatigue index [35].
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2.7. Histological Analysis of the Soleus Muscle
CSA of the soleus muscle and soleus muscle fibers were calculated according to Bodine and
Baar [39] and as described in our previous study [1]. The slides obtained from sections of the central
portion of the soleus muscle were stained with hematoxylin and eosin (HE). Photographs were taken
using an optical microscope (Nikon Eclipse E1000, Fukuoka, Japan) attached to a digital camera
(Nixon DXM 1200). The images were analyzed (150 fibers per muscle) using the AxioVision program
(version 4.8.1.0, Carl Zeiss Imaging Solutions, Jena, Germany).
2.8. Determination of Cathepsin L Activity in the Gastrocnemius Muscle
Cathepsin L activity was determined in the gastrocnemius muscle using the Cathepsin L Activity
Assay Kit (Abcam—ab65306, Abcam Inc., Cambridge, UK), according to the recommendations of the
manufacturer. The method was used in our previous study [1] and described by Jannig et al. [40].
2.9. 26S Proteasome Activity Measurement in the Gastrocnemius Muscle
Gastrocnemius muscle 26S proteasome activity was determined as described by Churchill et al. [41]
and Cunha et al. [42]. This assay was also used in our previous study [1]. In short, gastrocnemius
muscle was homogenized in a buffer (210 mmol/L D-mannitol; 70 mmol/L sucrose; 5 mmol/L MOPS;
and 1 mmol/L EDTA; pH 7.4). After centrifugation, the supernatant was used for determination
of cytosolic proteins. The activity of the chymotrypsin site of the 26S portion of the proteasome
was assessed by fluorometric assay. Measurements were performed in the absence and presence
of epoxomicin (20 lmol/L). The difference between the two rates was attributed to the proteasome
activity [42].
2.10. Analysis of Akt, S6, 4EBP1, GSK3-Beta, Atrogin-1/MAFbx, MuRF1 and ERK 1/2 in the Soleus Muscle
by Western Blot
Soleus muscles were homogenized and the total content of proteins was determined as previously
described [43]. Equal amounts of total protein (10 µg) were used to determine the content of signaling
molecules involved in the protein synthesis and degradation pathways as described in our previous
study [1]. Total loading of proteins for each sample, as indicated by the Ponceau S staining, was
used to normalize the results (Figure S1B) [1,44–46], expressed in values relative to the C57BL/6
control group. A pool sample, composed of equal parts of all experimental condition samples, was
used for normalization among membranes. The images were captured by the Amersham Imager 600
(Amersham/GE Healthcare) and quantified using the Image J software (NIH, Bethesda, MD, USA)
(Figure S1C). The primary antibodies used (dilution 1:1000) were: p-Akt at Ser 473 (9271), Akt (9272),
p-S6 (ribosomal protein S6) at Ser 240/244 (5364), S6 (2217), p-4EBP1 at Thr 37/46 (2855), 4EBP1
(9644), p-GSK3-beta at Ser 9 (9323), GSK3-beta (9315), p-ERK 1/2 at Thr 202/Tyr 204 (9101), and ERK
1/2 (4695) from Cell Signaling Technology (Danvers, MA, USA); and atrogin-1 (AP2041) and MuRF1
(MP3401) from ECM Biosciences (Versailles, KY, USA).
2.11. Statistical Analysis
Statistical analysis was performed using the GraphPad Prism® software (version 4.01; El Camino
Real, CA, USA). Results are presented as mean ± standard error of the mean (SEM). The overall
differences for C57BL/6 and C57BL/6 + HS vs. Fat-1 and Fat-1 + HS or for C57BL/6 and Fat-1 vs.
C57BL/6 + HS and Fat-1 + HS (main effects for Fat-1 or HS) were analyzed by two-way analysis
of variance (ANOVA). When significant difference was found, the Bonferroni post-hoc test was used
for differences between specific groups being detected. Grubb’s test was used to exclude outliers.
The differences were considered significant for p < 0.05.
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3. Results
3.1. Body Weight Gain
The C57BL/6 group had a body weight gain of 1.6 ± 0.3 g and the Fat-1 group 1.3 ± 0.4 g over the
two-week experimental period. The HS promoted a decrease in the body weight gain in both groups:
−0.7 ± 0.3 for the C57BL/6 and −1.7 ± 0.8 for the Fat-1 mice (Table 1).
Table 1. Body weight, skeletal muscles and fat depots mass and soleus protein content of the four
groups: C57BL/6, C57BL/6 + HS, Fat-1, and Fat-1 + HS.
C57BL/6 C57BL/6 + HS Fat-1 Fat-1 + HS
Body weight
Initial body weight (g) 23 ± 0.6 23 ± 0.5 22 ± 0.4 24 ± 0.7
Increase or decrease of body mass after 14 days (g) 1.6 ± 0.3 −0.7 ± 0.3 b 1.3 ± 0.4 −1.7 ± 0.8 c
Soleus muscle
Wet weight (mg/mm tibia length) 0.456 ± 0.019 0.263 ± 0.010 c 0.435 ± 0.013 0.319 ± 0.021 c,x
Percent loss due to HS in wet weight 42% 27%
Dry weight (mg/mm tibia length) 0.149 ± 0.010 0.112 ± 0.010 a 0.151 ± 0.017 0.137 ± 0.012
Percent loss due to HS in dry weight 25% 9%
Gastrocnemius muscle
Wet weight (mg/mm tibia length) 6.945 ± 0.168 5.334 ± 0.144 c 6.608 ± 0.213 5.473 ± 0.188 c
Percent loss due to HS in wet weight 23% 17%
Dry weight (mg/mm tibia length) 1.683 ± 0.046 1.320 ± 0.046 c 1.649 ± 0.056 1.355 ± 0.063 b
Percent loss due to HS in dry weight 22% 18%
Plantaris muscle
Wet weight (mg/mm tibia length) 0.892 ± 0.019 0.697 ± 0.010 c 0.914 ± 0.013 0.784 ± 0.021 c,y
Percent loss due to HS in wet weight 22% 14%
Dry weight (mg/mm tibia length) 0.218 ± 0.009 0.171 ± 0.006 b 0.232 ± 0.012 0.187 ± 0.010 b
Percent loss due to HS in dry weight 22% 19%
Tibialis anterior muscle
Wet weight (mg/mm tibia length) 2.237 ± 0.074 1.860 ± 0.063 c 2.369 ± 0.098 1.949 ± 0.071 b
Percent loss due to HS in wet weight 17% 18%
Dry weight (mg/mm tibia length) 0.635 ± 0.015 0.565 ± 0.025 0.645 ± 0.034 0.536 ± 0.025 a
Percent loss due to HS in dry weight 11% 17%
EDL muscle
Wet weight (mg/mm tibia length) 0.478 ± 0.020 0.434 ± 0.021 0.544 ± 0.015 x 0.469 ± 0.017 a
Percent loss due to HS in wet weight 9% 14%
Dry weight (mg/mm tibia length) 0.141 ± 0.009 0.122 ± 0.009 0.137 ± 0.007 0.128 ± 0.008
Percent loss due to HS in dry weight 14% 7%
Subcutaneous fat mass
Wet weight (mg/cm L) 22.49 ± 2.40 22.55 ± 2.98 21.03 ± 1.30 18.51 ± 2.46
Percent loss due to HS in wet weight 0% 12%
Epididymal fat mass
Wet weight (mg/cm L) 26.23 ± 1.56 15.37 ± 0.81 c 19.82 ± 1.30 y 11.16 ± 1.57 c
Percent loss due to HS in wet weight 41% 44%
Retroperitoneal fat mass
Wet weight (mg/cm L) 6.80 ± 0.93 7.40 ± 0.72 6.72 ± 0.46 4.56 ± 0.54 x
Percent loss due to HS in wet weight 0% 32%
Mesenteric fat mass
Wet weight (mg/cm L) 17.21 ± 2.96 13.35 ± 2.55 15.48 ± 2.57 12.90 ± 3.29
Percent loss due to HS in wet weight 22% 17%
Soleus total protein content
mg/g fresh tissue 34.33 ± 7.84 43.00 ± 9.72 62.47 ± 7.16 x 59.67 ± 1.22
Values are presented as mean ± SEM of at least seven animals. The results were compared using two-way ANOVA
and Bonferroni post-hoc test. The percentages indicate the effect of HS in the respective groups. a p < 0.05; b p < 0.01;
c p < 0.001 for significant differences using the Bonferroni post-hoc test between the HS groups and the respective
controls. x p < 0.05; y p < 0.01; z p < 0.001 for significant differences using the Bonferroni post-hoc test between the
C57BL/6 vs. Fat-1 groups (C57BL/6 vs. Fat-1 or C57BL/6 + HS vs. Fat-1 + HS). HS: the hindlimb suspension group;
EDL: extensor digitorum longus; L: length of the animal; SEM: standard error of the mean.
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3.2. Wet and Dry Mass of the Soleus, Gastrocnemius, Plantaris, Tibialis Anterior, and EDL Muscles, and Total
Protein Content in the Soleus Muscle
HS decreased soleus muscle wet and dry mass in C57BL/6 mice by 42% and 25%, respectively, and
in Fat-1 mice by 27% and 9%, respectively. As indicated by ANOVA and the Bonferroni post-test, Fat-1
mice had a less pronounced reduction of soleus muscle mass due to HS (Table 1). The gastrocnemius
muscle wet and dry mass were decreased by 23% and 22%, respectively, in C57BL/6 mice and by 17%
and 18%, respectively, in Fat-1 mice. Plantaris muscle wet and dry mass were reduced in C57BL/6
mice by 22%, and in Fat-1 mice by 14% and 19%, respectively, due to HS. Tibialis anterior muscle wet
and dry mass were decreased in C57BL/6 mice by 17% and 11%, respectively, and in Fat-1 mice by
18% and 17%, respectively. HS reduced EDL muscle wet and dry weights in C57BL/6 mice by 9% and
14%, respectively, and in Fat-1 mice by 14% and 7%, respectively. The effects of HS on soleus muscle
dry mass, gastrocnemius muscle wet and dry mass, plantaris muscle dry mass, tibialis anterior muscle
wet and dry mass and EDL muscle dry weight were not different between C57BL/6 and Fat-1 mice as
indicated by ANOVA and the Bonferroni post-hoc test. Soleus muscle total protein content (mg/g fresh
tissue) was significantly higher (p < 0.05) in Fat-1 as compared with C57BL/6 wild-type mice (Table 1).
3.3. Wet Mass of Subcutaneous, Epididymal, Retroperitoneal and Mesenteric Fat Depots
HS had no significant effect on subcutaneous and retroperitoneal fat depots in C57BL/6 mice.
However, HS decreased subcutaneous fat depot mass by 12% and retroperitoneal fat mass by 32% as
compared with non-HS Fat-1 mice. The epididymal fat mass was reduced due to HS (p < 0.001); by 41%
in C57BL/6 mice and by 44% in Fat-1 mice. HS decreased the mesenteric fat mass by 22% in C57BL/6
mice and by 17% in Fat-1 mice (Table 1). Fat-1 had a significant reduction in epididymal (C57BL/6 vs.
Fat-1 groups, p < 0.01) and retroperitoneal (C57BL/6 + HS vs. Fat-1 + HS groups, p < 0.05) fat depots
as indicated by Bonferroni post-hoc test.
3.4. Gastrocnemius Muscle Fatty Acid Composition
As indicated by ANOVA and the Bonferroni post-hoc test, the ω-6/ω-3 PUFA ratio was decreased
in the gastrocnemius muscle of the C57BL/6 + HS group as compared with C57BL/6 mice (p < 0.01)
and of Fat-1 as compared with C57BL/6 mice either without HS (C57BL/6 vs. Fat-1, p < 0.001) or with
HS (C57BL/6 + HS vs. Fat-1 + HS, p < 0.01). The values were: 2.62 ± 0.39 for C57BL/6; 2.11 ± 0.27 for
C57BL/6 + HS; 1.14 ± 0.27 for Fat-1 and 0.79 ± 0.11 for Fat-1 + HS (Table 2).
Table 2. Composition of fatty acids in the gastrocnemius muscle (g/100 g wet weight).
Fatty Acid Name C57BL/6 C57BL/6 + HS Fat-1 Fat-1 + HS
14:0 Myristic 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00 0.01 ± 0.00
16:0 Palmitic 0.29 ± 0.04 0.28 ± 0.02 0.23 ± 0.10 0.30 ± 0.03
16:1 (ω-7) Hexadecenoic 0.03 ± 0.01 0.04 ± 0.01 0.02 ± 0.01 0.05 ± 0.01 c
17:0 Margaric - - - -
18:0 Stearic 0.14 ± 0.02 0.13 ± 0.01 0.11 ± 0.05 0.13 ± 0.01
18:1 (ω-9) Oleic 0.18 ± 0.06 0.15 ± 0.04 0.13 ± 0.07 0.18 ± 0.04
18:1 (ω-11) Vaccenic 0.04 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 0.04 ± 0.00
18:2 (ω-6) Linoleic 0.25 ± 0.07 0.21 ± 0.03 0.21 ± 0.09 0.24 ± 0.04
20:0 Eicosanoic - - - -
20:1 (ω-9) Eicosenoic - - - -
18:3 (ω-6) γ-Linolenic - - - -
18:3 (ω-3) α-Linolenic 0.01 ± 0.01 0.01 ± 0.00 0.01 ± 0.01 0.02 ± 0.01
22:0 Docosanoic - - - -
20:2 (ω-6) Eicosadienoic 0.01 ± 0.00 - - -
20:3 (ω-9) Eicosatrienoic 0.01 ± 0.00 0.01 ± 0.00 - -
20:4 (ω-6) Arachidonic 0.13 ± 0.01 0.13 ± 0.02 0.02 ± 0.01 z 0.01 ± 0.00 z
22:2 (ω-6) Docosadienoic - - - —
20:5 (ω-3) Eicosapentaenoic - - 0.01 ± 0.00 0.02 ± 0.01
22:4 (ω-3) Docosatetraenoic 0.02 ± 0.00 0.02 ± 0.00 - -
22:5 (ω-6) Docosapentaenoic 0.02 ± 0.00 0.02 ± 0.00 - -
22:5 (ω-3) Docosapentaenoic 0.02 ± 0.00 0.03 ± 0.00 0.05 ± 0.02 z 0.06 ± 0.01 z
22:6 (ω-3) Docosahexaenoic 0.13 ± 0.02 0.15 ± 0.04 0.15 ± 0.07 0.21 ± 0.03
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Table 2. Cont.
Fatty Acid Name C57BL/6 C57BL/6 + HS Fat-1 Fat-1 + HS
Total
Saturated 0.44 ± 0.06 0.42 ± 0.03 0.35 ± 0.16 0.44 ± 0.04
Monounsaturated 0.25 ± 0.08 0.23 ± 0.06 0.18 ± 0.09 0.27 ± 0.06
Polyunsaturated 0.59 ± 0.11 0.57 ± 0.08 0.45 ± 0.20 0.56 ± 0.06
ω-3 0.16 ± 0.03 0.19 ± 0.04 0.22 ± 0.10 0.31 ± 0.04 a,y
ω-6 0.42 ± 0.08 0.39 ± 0.04 0.23 ± 0.10 z 0.25 ± 0.04 y
ω-6/ω-3 ratio 2.62±0.39 2.11 ± 0.27 b 1.14 ± 0.27 z 0.79 ± 0.11 y
Total fat % 1.37±0.25 1.32 ± 0.17 1.25 ± 0.10 1.37 ± 0.16
The determination of fatty acid by gas chromatography was calculated from the tridecanoate triglyceride, which
was used as internal standard. Values are presented as mean ± SD, n = 6–7 per group. The results were compared
using two-way ANOVA and Bonferroni post-hoc test. a p < 0.05; b p < 0.01; c p < 0.001 for: significant differences
using the Bonferroni post-hoc test between the hindlimb suspension groups and the respective controls. x p < 0.05;
y p < 0.01; z p < 0.001 for: significant differences using the Bonferroni post-hoc test between the C57BL/6 vs. Fat-1
groups (C57BL/6 vs. Fat-1 or C57BL/6 + HS vs. Fat-1 + HS). HS: hindlimb suspension; SD: standard deviation;
-: not detected.
3.5. Analysis of Strength, Contractile Properties and Resistance to Fatigue in the Soleus Muscle
Absolute isotonic force was decreased in the soleus muscle due to HS in the C57BL/6 mice
(p < 0.01). This decrease was less pronounced in balanced diet-fed Fat-1 mice (Figure 1A). Absolute
tetanic force in the soleus muscle was not significantly different between C57BL/6 and Fat-1 mice,
as indicated by the intra-group analysis using Bonferroni post-hoc test. However, as indicated by
ANOVA (with no post-hoc test difference), HS reduced the absolute tetanic force in the soleus muscle
(p < 0.01) as compared with non-HS in both groups (Figure 1B). The contractile properties (TTP, HRT,
LRT in Figure 1C–E, respectively) as well as the resistance to fatigue (Figure 1F,G) did not change
significantly in the soleus muscle among the groups. Based on the inclination of the fatigue curve, there
is a trend for increase fatigue resistance mainly after 5th contraction in Fat-1 mice when compared
with C57BL/6 wild type. The values were: −1.13 ± 0.21 for C57BL/6; −1.04 ± 0.24 for C57BL/6 + HS;
−0.44 ± 0.35 for Fat-1; and −0.65 ± 0.28 for Fat-1 + HS.
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ω-3 0.16 ± 0.03 0.19 ± 0.04 0.22 ± 0.10 0.31 ± 0.04 a,y 
ω-6 0.42 ± 0.08 0.39 ± 0.04 0.23 ± 0.10 z 0.25 ± 0.04 y 
ω-6/ω-3 ratio 2.62±0.39 2.11 ± 0.27 b 1.14 ± 0.27 z 0.79 ± 0.11 y 
Total fat % 1.37±0.25 1.32 ± 0.17 1.25 ± 0.10 1.37 ± 0.16 
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triglyceride, which was used as internal standard. Values are presented as mean ± SD, n = 6–7 per 
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using the Bonferroni post-hoc test between the C57BL/6 vs. Fat-1 groups (C57BL/6 vs. Fat-1 or C57BL/6 
+ HS vs. Fat-1 + HS). HS: hindlimb suspension; SD: st dard dev ation; -: not detected.  
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Figure 1. Muscle strength, contractile properties and muscle fatigue of the four groups studied 
(C57BL/6, C57BL/6 + HS, Fat-1, Fat-1 + HS) in the soleus muscle. Muscle strength: A. Absolute isotonic 
force. B. Absolute tetanic force. Contractile properties: C. TTP; D. HRT; E. LRT. Muscle fatigue: F and 
G. Resistance to fatigue (force vs contraction). Values are presented as mean ± SEM, n = 5–8 animals. 
The results were compared using two-way ANOVA and Bonferroni post-hoc test. In A, p < 0.01 
indicates significant difference using the Bonferroni post-hoc test. In B, * p < 0.01 for C57BL/6 and Fat-
1 groups vs. C57BL/6 + HS and Fat-1 + HS groups (main effect of HS), using two-way ANOVA only 
(no statistical differences using the Bonferroni post-hoc test). HS: hindlimb suspension; TTP: time to 
peak; HRT: half relaxation time; LRT: late relaxation time. 
Figure 1. Muscle strength, contractile properties and muscle fatigue of the four groups studied
(C57BL/6, C57BL/6 + HS, Fat-1, Fat-1 + HS) in th soleus muscle. Muscle strength: (A) Absolute
isotonic force. (B) Absolute tetanic force. Contractile properties: (C) TTP; (D) HRT; (E) LRT. Muscle
fatigue: (F) and (G) Resistance to fatigue (force vs contraction). Values are presented as mean ± SEM,
n = 5–8 animals. The results were compared using two-way ANOVA and Bonferroni post-hoc test.
In (A), p < 0.01 indicates significant difference using the Bonferroni post-hoc test. In (B), * p < 0.01 for
C57BL/6 and Fat-1 groups vs. C57BL/6 + HS and Fat-1 + HS groups (main effect of HS), using two-way
ANOVA only (no statistical differences using the Bonferroni post-hoc test). HS: hindlimb suspension;
TTP: time to peak; HRT: half relaxation time; LRT: late relaxation time.
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3.6. CSA of the Soleus Muscle and of Soleus Muscle Fibers
Soleus muscle CSA was significantly decreased (p < 0.05) in the C57BL/6 mice due to HS.
The decrease in soleus muscle CSA induced by HS was less pronounced in the balanced
diet-fed Fat-1 mice (Figure 2A,B). HS decreased CSA of the soleus muscle fibers in both groups
(C57BL/6 vs. C567BL/6 + HS, p < 0.001 and Fat-1 vs. Fat-1 + HS, p < 0.01) (Figure 2C,D).
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Figure 2. Cross-sectional areas (CSA) of the soleus muscle and soleus muscle fibers of the four groups
studied (C57BL/6, C57BL/6 + HS, Fat-1, Fat-1 + HS). (A) Representative histological hematoxylin and
eosin staining images of cross-sectional areas of the whole soleus muscle. a. C57BL/6; b. C57BL/6 + HS;
c. Fat-1; d. Fat-1 + HS. Reference bar represents 200 µm. (B) Cross-sectional area of the soleus muscle.
Values are presente as mean ± SEM, n = 7–8 animals. (C) R presentative histological hematoxylin and
eosin staining images of cross-sectional ar as of soleus muscle fibers. a. C57BL/6; b. C57BL/6 + HS;
c. Fat-1; d. Fat-1 + HS. Reference bar represents 50 µm. (D) Cross-sectional areas of s leus muscle fibers.
Values are presented as mean ± SEM, n = 6–8. The results were compared using two-way ANOVA and
Bonferroni post-hoc test. In (B) and (D), p values indicate significant differences using the Bonferroni
post-hoc test. HS: hindlimb suspension; CSA: Cross-sectional area. 3.7. Activities of Cathepsin L and
26S Proteasome in the Gastrocnemius Muscle, and Contents of Atrogin-1/MAFbx and MuRF1 in the
Soleus Muscle.
Cathepsin L activity was lowered (p < 0.05) in the gastrocnemius muscl of Fat-1 as compared with
the C57BL/6 mice (Figure 3A). HS had n significant effect on cathepsin L in both groups. The activity
of 26S proteasome was not changed in the gastrocnemius muscle after two-week HS in both groups
(Figure 3B). The content of atrogin-1/MAFbx was not significantly changed (Figure 3C) but MuRF1
content was decreased (p < 0.05) in the soleus muscle due to HS in Fat-1 mice (Figure 3D). C57BL/6
mice did not exhibit significant changes due to HS in atrogin-1/MAFbx and MuRF-1 contents.
Nutrients 2017, 9, 1100 9 of 16
Nutrients 2017, 9, 1100 9 of 15 
C57BL/6 mice did not exhibit significant changes due to HS in atrogin-1/MAFbx  
and MuRF-1 contents.  
 
Figure 3. (A) Cathepsin L activity in the gastrocnemius muscle of the four groups studied (C57BL/6, 
C57BL/6 + HS, Fat-1, Fat-1 + HS). (B) 26S proteasome activity in the gastrocnemius muscle. (C) atrogin-
1/MAFbx and D. MuRF-1 content in soleus muscle. Values are presented as mean ± SEM on the basis 
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the C57BL/6 control group, n = 5–8 animals. The results were compared using two-way ANOVA and 
Bonferroni post-hoc test. In A and D, p ˂ 0.05 indicates significant differences using the 
Bonferroni post-hoc test. HS: hindlimb suspension. 
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Protein synthesis signaling had a slight reduction (without significant changes as indicated by 
ANOVA and the Bonferroni post-hoc test) due to HS: p-Akt, p-S6, total S6, total GSK3B, phospho- and 
total-ERK 1/2 (Figures S2 and S3). p-GSK3B/total GSK3B ratio was increased (p < 0.01) in the Fat-1 
group due to HS as indicated by the Bonferroni post-hoc test (Figure S2L).  
4. Discussion 
This study is the first to use Fat-1 transgenic mice in an experimental model of skeletal muscle 
disuse atrophy in which neural activity was maintained [25,26]. We were able to characterize the 
soleus muscle disuse atrophy in an experimental model that mimics a bed rest condition in humans 
[47]. The measurements were performed after 14 days of HS in order to investigate the changes in the 
period when muscles composed mainly of oxidative/slow twitch/type I fibers (in soleus and 
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dry mass loss and partially preserved the absolute isotonic force and CSA in the soleus muscle after 
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Figure 3. (A) Cathepsin L activity in the gastrocnemius muscle of the four groups studied (C57BL/6,
C57BL/6 + HS, Fat-1, Fat-1 + HS). (B) 26S proteasome activity in the gastrocnemius muscle.
(C) atrogin-1/MAFbx and (D) MuRF-1 content in soleus muscle. Values are presented as mean ± SEM
on the basis of total protein loading as indicated by the Ponceau S measurement (C,D) and expressed
relative to the C57BL/6 control group, n = 5–8 animals. The results were compared using two-way
ANOVA and Bonferroni post-hoc test. In (A) and (D), p < 0.05 indicates significant differences using the
Bonferroni post-hoc test. HS: hindlimb suspension.
3.7. Protein Synthesis-Associated Signaling in Soleus Muscle
Protein synthesis signaling had a slight reduction (without significant changes as indicated by
ANOVA and the Bonferroni post-hoc test) due to HS: p-Akt, p-S6, total S6, total GSK3B, phospho- and
total-ERK 1/2 (Figures S2 and S3). p-GSK3B/total GSK3B ratio was increased (p < 0.01) in the Fat-1
group due to HS as indicated by the Bonferroni post-hoc test (Figure S2L).
4. Discussion
This study is the first to use Fat-1 transgenic mice in an experimental model of skeletal muscle
disuse atrophy in which eural activity was maintained [25,26]. We were able to characterize the soleus
muscl disuse atrophy in an experimental model that mimics a bed rest conditio in h m s [47].
The measurement were performed after 14 days of HS in order to investigat the changes in the period
when muscles composed mainly of oxidative/slow twitch/type I fibers (in soleus and gastrocnemius
muscles) have the highest percentage of mass loss [2]. Novel results are reported that motivate the
investigation of the full mechanisms involved.
Balanced diet-fed Fat-1 mice, with no HS, had decreased totalω-6 fatty acid content andω-6/ω-3
fatty acids ratio in the gastrocnemius skeletal muscle associated with higher EDL wet muscle mass,
when compared with the C57BL/6 mice. Fat-1 mice had also decreased cathepsin L activity in the
gastrocnemius muscle and increased soleus muscle total protein content. Fat-1 mice had a lowered
dry mass loss and partially preserved the absolute isotonic force and CSA in the soleus muscle after
HS period.
HS reduced the body weight and fat mass in both groups as also previously reported by
others [48,49]. We observed a decrease of the weight gain in the animals submitted to HS. Similar
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results were reported by Lloyd et al. (2014) in C57BL/6 mice after 7, 14 and 21 days of HS [49]. We also
observed a reduction in the fat mass that is in accordance with reports by others [50–52].
As reported in our last work [1] and by others [2,53–57], the percentages of skeletal muscle mass
loss induced by HS were different among the skeletal muscles. Soleus muscle was the most affected.
Soleus muscle has predominantly oxidative/slow twitch/type I fibers that are associated with greater
mass loss due to gravity withdrawn conditions as in HS [2]. The HS effects were less pronounced in
muscles with a predominance of glycolytic/fast twitch/type II fibers. Hanson et al. (2013) reported a
25% reduction of soleus muscle mass in C57BL/6 mice after 14 days of HS, equal to the dry weight
decrease herein described (25%) [58]. Attenuation in the decrease of soleus muscle dry mass induced
by HS was observed in Fat-1 mice.
The gastrocnemius muscle was the second mostly affected (in the percentage of mass loss due
to HS). Gastrocnemius muscle of Fat-1 mice had an increase of ω-3 PUFAs, decrease of ω-6 PUFAs,
and consequently a decrease in the ω-6/ω-3 PUFA ratio [24,27]. The effects of the EPA are more
pronounced as compared with DHA in conditions of muscle disuse atrophy [1] or aging [59].
HS had very little effect on skeletal muscle fatty acid composition. However, we measured the
fatty acid composition of the gastrocnemius muscle only, so we cannot rule out the possibility that
differences in composition of fatty acids [60] and in intramyocellular lipid droplet accumulation [61]
may occur between slow- and fast-twitch muscle fibers and whether this may have a role in the
muscle-specific effects reported. Rat slow-twitch fibers have a lower content of EPA and DHA and also
a higher ω-6/ω-3 PUFA ratio [60]. It may be associated to the increased susceptibility of the soleus
muscle to HS-induced atrophy. The increased content ofω-3 PUFA in Fat-1 mice may be more relevant
to the soleus muscle that exhibited the greatest atrophy attenuation.
HS decreased skeletal muscle force and resistance to fatigue as also reported by others [58,62,63].
Fat-1 mice submitted to HS had lower decrease of the absolute isotonic force and a less pronounced
reduction in skeletal muscle force after the fifth contraction (without significant changes) and it became
more pronounced by HS. ω-3 PUFAs preserve skeletal muscle function in humans with skeletal
muscle atrophy [16,17,64] and this effect is associated with increased mitochondrial biogenesis [17,59],
improved ATP resynthesis and/or sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump activity
during skeletal muscle contraction [65]. The same reduction in mitochondrial biogenesis is reported in
mice during hindlimb suspension [54]. Theω-3 PUFAs may have a role in preventing the decrease in
mitochondria biogenesis, which contributes, not only to improve fatigue resistance and contractile
properties but for the maintenance of muscle mass during HS suspension.
Peoples and McLennan (2010) investigated the effects of an eight-week administration of a
diet rich with in saturated fatty acids, ω-6 or ω-3 PUFAs in rats. Animals fed with a diet rich in
ω-3 PUFAs (high-DHA tuna fish oil) had a delay in muscle fatigue, improved contractile function
recovery, and reduced consumption of oxygen during skeletal muscle contraction. The protocol of
electrical stimulation used to promote skeletal muscle fatigue was different from the one herein used;
1 Hz vs. 100 Hz of frequency and gastrocnemius-plantaris-soleus vs. soleus muscles, respectively [66].
The same group, using a slightly different electrical stimulation protocol (5 Hz), reported that, after
15 weeks of low or moderate fish oil (0.31% and 1.25%, respectively) containing diet (high-DHA tuna
fish oil), no differences were observed in the maximum skeletal muscle force when compared with
control animals (10% of olive oil according to body weight). The resistance to fatigue was elevated in
the fish oil-fed group and this observation was associated with increased incorporation of DHA in
sarcoplasmic membranes. ω-3 PUFAs may then improve fatigue resistance in a muscle type-specific
way, as it had an effect in glycolytic/white gastrocnemius muscle but not in oxidative/soleus
muscle [67]. In this study no increased tetanic force was reported.
The attenuation of the CSA reduction due to HS in the soleus muscle of Fat-1 mice is in line with the
findings reported for the muscle dry mass and absolute isotonic force, in which the statistical differences
between the Fat-1 and Fat-1 + HS groups are abolished. HS did not change the levels of the protein
degradation signaling in soleus muscle. Two weeks of HS did not increase the cathepsin L activity as
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also reported in our previous study in rats [1], neither 26S proteasome activity nor atrogin-1/MAFbx
content. The protein degradation activity may play a significant role at the beginning of the process,
contributing to the establishment of the skeletal muscle atrophy. This metabolic feature does not persist
in a prolonged period of muscle disuse induced atrophy as reported by others [2,3,49,58,68].
The levels of some signaling molecules (Akt, S6, ERK 1/2) of the protein synthesis pathway
were slightly (not significantly) decreased due to HS, as also reported by others after muscle disuse
atrophy [2,3,49,58,68]. The ω-3 PUFAs promote anabolism by increasing insulin sensitivity and
activating the Akt-mTOR-S6 signaling [20]. Theω-3 PUFAs improve mitochondrial biogenesis [17,59]
and modify mitochondrion membrane composition [65].
Lim et al. (2013) investigated skeletal muscle atrophy in Fat-1 mice using an acute SCI model.
After 28 days, the Fat-1 mice exhibited a reduced impact of the SCI and improved locomotor recovery
as compared with the C57BL/6 wild-type mice [25]. The same group described that, after seven days
of peripheral nerve injury (PNI) (sciatic nerve), Fat-1 mice displayed neuroprotective effects and had a
pro-regenerative potential increased as compared with C57BL/6 wild-type [26]. Both studies were
performed on a diet rich inω-6 PUFAs and poor inω-3 PUFAs.
We previously reported that supplementation with high levels ofω-3 PUFAs, which induced a
four-fold decrease in gastrocnemiusω-6/ω-3 PUFA ratio, did not attenuate the soleus muscle mass
loss after 14 days of HS [1]. In the present study, a chronic increase in the amount ofω-3 PUFAs, with
aω-6/ω-3 PUFA ratio only 56% lower than that of the control, preserved the skeletal muscle mass in
HS with minor changes in protein synthesis and degradation signaling.
The HS effects on soleus muscle atrophy were possibly less pronounced in Fat-1 mice due to
PUFAs anabolic actions. The muscle contraction preserves muscle mass but, without the mechanical
loading, it is insufficient to prevent the complete muscle mass loss. The effects of ω-3 PUFAs are
possibly increased when associated with muscle activation/loading conditions as in physical exercise,
neuromuscular electrical stimulation or mechanical loading.
Despite the originality and relevance of the present study, some limitations have to be considered.
The authors did not investigate the effect of aω-6 PUFAs rich diet, the early consequences of HS in both
groups (for instance three or five days of HS) or upstream degradation markers, downstream effectors
and final responses on protein synthesis and degradation. Caspase/calpain activity production
of reactive oxygen species (ROS) and endoplasmic reticulum stress may also be involved in the
HS-induced muscle atrophy [9,69–71].
5. Conclusions
In conclusion, a slight increase of ω-3 PUFAs in the skeletal muscle tissue preserved skeletal
muscle mass when the mice faced a muscle disuse condition. The consequences (decrease of skeletal
muscle mass, absolute isotonic force and soleus muscle CSA) induced by the skeletal muscle disuse
were less pronounced in balanced diet-fed Fat-1 mice.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/10/1100/s1,
Figure S1: Image to confirm C57BL/6 wild-type mice or Fat-1 transgenic mice lineage; Ponceau S staining used
as loading control, and Images of the western blot assays used in this study, Figure S2: Contents of proteins
associated with signaling pathways of protein synthesis in the soleus muscle of the four groups studied (C57BL/6,
C57BL/6 + HS, Fat-1, Fat-1 + HS), Figure S3: Results of the quantitative analysis of western blot assay used in the
Figure S2 of this study.
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